HAIFA, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its proprietary platform for cell-based solutions through a collaborative network of ventures, today announced expansion of its manufacturing agreement signed in 2024 with Remedy Cell Ltd. (“Remedy Cell”), an innovative biopharmaceu...
Plurilock Security Inc. ( PLUR:CA ) Q3 2025 Earnings Call November 27, 2025 11:00 AM EST Company Participants Ian Paterson - CEO & Director Scott Meyers - CFO & Corporate Secretary Conference Call Participants Ryan Freemantle Presentation Ryan Freemantle Good morning, and thank you for joining us for Plurilock Securities conference call to discuss its financial results for the quarter ending Se...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.